Susquehanna Fundamental Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-33,179
Closed -$4.07M 561
2025
Q4
$4.07M Sell
33,179
-39,062
-54% -$4.75M 0.14% 159
2025
Q3
$8.02M Sell
72,241
-199,430
-73% -$22.7M 0.31% 82
2025
Q2
$30.1M Hold
271,671
0.81% 23
2025
Q1
$30.4M Sell
271,671
-25,355
-9% -$2.62M 0.43% 39
2024
Q4
$27.4M Buy
+297,026
New +$26.7M 0.39% 41
2023
Q3
Sell
-114,568
Closed -$8.83M 466
2023
Q2
$8.83M Hold
114,568
0.32% 88
2023
Q1
$9.51M Sell
114,568
-50,885
-31% -$4.21M 0.22% 130
2022
Q4
$14.2M Sell
165,453
-178,817
-52% -$14.2M 0.25% 120
2022
Q3
$21.2M Buy
+344,270
New +$21.7M 0.36% 56
2022
Q1
$5.65M Hold
95,095
0.11% 259
2021
Q4
$6.91M Sell
95,095
-8,132
-8% -$560K 0.18% 138
2021
Q3
$7.21M Buy
103,227
+61,427
+147% +$4.32M 0.13% 199
2021
Q2
$2.88M Buy
+41,800
New +$2.79M 0.05% 470
2020
Q3
Sell
-41,600
Closed -$3.2M 1361
2020
Q2
$3.2M Buy
41,600
+28,600
+220% +$2.19M 0.15% 168
2020
Q1
$972K Sell
13,000
-8,197
-39% -$566K 0.19% 135
2019
Q4
$1.38M Sell
21,197
-1,800
-8% -$117K 0.18% 151
2019
Q3
$1.46M Buy
22,997
+12,797
+125% +$837K 0.18% 156
2019
Q2
$689K Sell
10,200
-84,700
-89% -$5.57M 0.08% 227
2019
Q1
$6.17M Buy
94,900
+34,600
+57% +$2.3M 0.7% 40
2018
Q4
$3.77M Buy
+60,300
New +$4.21M 0.66% 40
2018
Q2
Sell
-73,700
Closed -$5.56M 424
2018
Q1
$5.56M Buy
+73,700
New +$5.86M 0.66% 23

Other funds holding GILD

Susquehanna Fundamental Investments's GILD Position: Q1 2026 in Review

Susquehanna Fundamental Investments sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 33,179 shares — an estimated $4.07M sold.

Susquehanna Fundamental Investments first reported a position in GILD in Q1 2018 and held it in 21 quarters. The position peaked at $30.4M in Q1 2025. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Susquehanna Fundamental Investments reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 33,179 Gilead Sciences shares in Q1 2026, an estimated $4.07M.
  • Susquehanna Fundamental Investments first reported a position in Gilead Sciences in Q1 2018 and held it in 21 quarters.
  • Susquehanna Fundamental Investments's Gilead Sciences position peaked at $30.4M in Q1 2025.
  • 2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.